OA10282A - Procédé de préparation de compositions orales contenant des quinolones - Google Patents

Procédé de préparation de compositions orales contenant des quinolones Download PDF

Info

Publication number
OA10282A
OA10282A OA60816A OA60816A OA10282A OA 10282 A OA10282 A OA 10282A OA 60816 A OA60816 A OA 60816A OA 60816 A OA60816 A OA 60816A OA 10282 A OA10282 A OA 10282A
Authority
OA
OAPI
Prior art keywords
radical
quinolones
compression
grinding
mixture
Prior art date
Application number
OA60816A
Other languages
English (en)
French (fr)
Inventor
Gabriel Gousset
Philippe Riviere
Original Assignee
Rhone Dpc Europ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Dpc Europ filed Critical Rhone Dpc Europ
Publication of OA10282A publication Critical patent/OA10282A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
OA60816A 1993-10-21 1996-04-19 Procédé de préparation de compositions orales contenant des quinolones OA10282A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9312550A FR2711524B1 (fr) 1993-10-21 1993-10-21 Procédé de préparation de compositions orales contenant des quinolones.

Publications (1)

Publication Number Publication Date
OA10282A true OA10282A (fr) 1997-10-07

Family

ID=9452072

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60816A OA10282A (fr) 1993-10-21 1996-04-19 Procédé de préparation de compositions orales contenant des quinolones

Country Status (30)

Country Link
US (1) US5840333A (de)
EP (1) EP0724442A1 (de)
AT (1) ATA905894A (de)
AU (1) AU7997094A (de)
BE (1) BE1007326A3 (de)
CA (1) CA2174444A1 (de)
CH (1) CH686555A5 (de)
CO (1) CO4180603A1 (de)
CZ (1) CZ113696A3 (de)
DZ (1) DZ1818A1 (de)
EE (1) EE9600050A (de)
ES (1) ES2126474B1 (de)
FI (1) FI961717L (de)
FR (1) FR2711524B1 (de)
GB (1) GB2297908B (de)
GR (1) GR1002181B (de)
HU (1) HUT74181A (de)
IE (1) IE940838A1 (de)
IT (1) IT1270672B (de)
LU (1) LU88724A1 (de)
MA (1) MA23331A1 (de)
NO (1) NO961429L (de)
NZ (1) NZ274874A (de)
OA (1) OA10282A (de)
PL (1) PL314005A1 (de)
SG (1) SG52202A1 (de)
SK (1) SK50596A3 (de)
TN (1) TNSN94110A1 (de)
WO (2) WO1995011023A1 (de)
ZA (1) ZA948175B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN186245B (de) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
DE69934582T2 (de) * 1998-06-11 2007-10-04 Pharmacia & Upjohn Co. Llc, Kalamazoo Delavirdin tablettenformulierung
US6342598B1 (en) 1998-11-26 2002-01-29 Bracco International B.V. Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents
JP4792032B2 (ja) 2004-08-13 2011-10-12 シェーリング−プラウ・リミテッド 抗生物質、トリアゾールおよびコルチコステロイドを含む薬学的処方物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639458A (en) * 1985-01-22 1987-01-27 Merck & Co., Inc. Tablet and formulation
JPH01175936A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd ６．８−ジフルオロ−１−（２−フルオロエチル）−１，４−ジヒドロ−７−（４−メチル−１−ピペラジニル）−４−オキソ−３−キノリンカルボン酸を有効成分とする錠剤
US4973470A (en) * 1989-06-26 1990-11-27 Warner-Lambert Company Sustained release pharmaceutical compositions
JPH10175936A (ja) * 1996-12-17 1998-06-30 Kao Corp 新規アミドアミノポリカルボン酸又はその塩、及びそれを含有する洗浄剤組成物

Also Published As

Publication number Publication date
GR1002181B (en) 1996-03-12
FI961717A7 (fi) 1996-04-19
FR2711524A1 (fr) 1995-05-05
FR2711524B1 (fr) 1995-11-24
IT1270672B (it) 1997-05-07
HU9601041D0 (en) 1996-06-28
ITMI942130A1 (it) 1996-04-19
ATA905894A (de) 2000-06-15
BE1007326A3 (fr) 1995-05-16
SG52202A1 (en) 1998-09-28
IE940838A1 (en) 1995-05-03
AU7997094A (en) 1995-05-08
TNSN94110A1 (fr) 1995-09-21
CA2174444A1 (fr) 1995-04-27
ES2126474A1 (es) 1999-03-16
PL314005A1 (en) 1996-08-05
FI961717A0 (fi) 1996-04-19
NZ274874A (en) 1997-10-24
NO961429D0 (no) 1996-04-11
LU88724A1 (fr) 1996-08-23
SK50596A3 (en) 1997-02-05
CZ113696A3 (en) 1996-07-17
FI961717L (fi) 1996-04-19
ITMI942130A0 (it) 1994-10-19
MA23331A1 (fr) 1995-04-01
NO961429L (no) 1996-04-11
ES2126474B1 (es) 1999-11-16
DZ1818A1 (fr) 2002-02-17
GB2297908A (en) 1996-08-21
CO4180603A1 (es) 1995-06-07
GB9608316D0 (en) 1996-06-26
EP0724442A1 (de) 1996-08-07
WO1995011022A1 (fr) 1995-04-27
ZA948175B (en) 1995-06-08
CH686555A5 (fr) 1996-04-30
US5840333A (en) 1998-11-24
WO1995011023A1 (fr) 1995-04-27
HUT74181A (en) 1996-11-28
EE9600050A (et) 1996-10-15
GB2297908B (en) 1997-12-10

Similar Documents

Publication Publication Date Title
KR101640164B1 (ko) ２­옥소­１­피롤리딘 유도체를 포함하는 약학적 조성물
EP1467724B1 (de) In der mundhöhle dispergierbare pharmazeutische zusammensetzung mit agomelatin
CA2446781A1 (fr) Granules enrobes a base d'inhibiteur de l'enzyme de conversion de l'angiotensine
EP0614362B1 (de) Ebastin oder ebastin-analoga enthaltende arzneimittel
BE1011401A3 (fr) Nouvelle composition pour inhalation.
EP1334725B1 (de) Östroprogestatives Antikonzeptionsmittel
JPH06510532A (ja) 医薬品組成物の製造法
EP0497331B1 (de) Verfahren zur Herstellung von Tabletten oder filmbeschichteten Tabletten
JPWO2008111674A1 (ja) 口腔粘膜貼付ブプレノルフィン製剤の製造方法
BE1007326A3 (fr) Procede de preparation de compositions orales contenant des quinolones.
EP1654195B1 (de) Verfahren zur herstellung von calciumphosphatkörnen vom hydroxylapatit-typ
FR2705895A1 (fr) Comprimés médicamenteux exempts d'agent lubrifiant.
HU200924B (en) Process for producing pharmaceutical compositions comprising terfenadine
JP2008169135A (ja) グリメピリド組成物の製造方法
EP1646373B1 (de) Orodispersible pharmazeutische zusammensetzung einer antithrombotischen verbindung
JP2000516601A (ja) 水溶性化合物及びセルロースを含有する粒状物
CA2627608A1 (fr) Azodicarbonamide micronise, sa preparation et son utilisation
FR2640876A1 (de)
JP2004517111A (ja) シタロプラムを含有する薬学的調合物
JP2007332074A (ja) 口腔内速崩壊錠およびその製造方法
KR102887639B1 (ko) 생산성 및 용출성이 개선된 소라페닙 토실레이트염의 제제 및 그 제조 방법
JPH11286456A (ja) 複合粉体組成物及び錠剤
CN111035621A (zh) 洛伐他汀快速释放制剂及其制备方法
BE842564A (fr) Composition anti-allergique
KR20210105381A (ko) 리팍시민 정제의 제조 방법 및 리팍시민 정제